To better understand the regulation of interleukin-9 (IL-9) receptor expression, we have isolated the genomic clone of the human IL-9 receptor based on its sequence homology with a human IL-9 receptor cDNA isolated from the human megakaryocyte cell line UT-7. The entire genomic structure has been determined. The human IL-9 receptor gene consists of I O exons spread over approximately 13.7 kb of DNA. The nucleotide sequence of the coding region from the genomic DNA is identical to our cDNA clone. Several blocks of tran-I NTERLEUKIN-9 (IL-9) was originally identified by its ability to support the growth of helper T cells,'-' but its potential targets have been shown to include mast cells, megakaryoblastic leukemia cells, fetal thymocytes, murine erythroid progenitors, and human erythroid and myeloid prec u r s o r~.~"~ Involvement of IL-9 in tumorigenesis has been suggested by the observation that murine helper T cells become tumorigenic after transfection with IL-9 cDNA."
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The murine IL-9 receptor was recently characterized. A single class of receptor of 64 kD was determined on a Tcell clone." Murine and human IL-9 receptor cDNAs have been isolated by expression cloning from the murine T-cell clone TS1 and the human megakaryoblastic leukemia cell line Mo7E. 13 We report here an independent isolation of the human IL-9 receptor cDNA and cloning and analysis of the complete human IL-9 receptor genomic DNA.
MATERIALS AND METHODS
isolation of human K -9 receptor cDNA clone. Human IL-9 receptor cDNA clone was isolated from the cDNA library of the human megakaryocyte cell line, UT-7 cells. A mixture of degenerate synthetic oligonucleotides encoding the WSXWS motif (Trp-Ser-X [Glu, Pro, Ala, Ser, Asp]-Trp-Ser) was used as a hybridization probe. The oligonucleotide sequences are the mixture of A TAA
TGG-AGF-GCG-TGG-AG? c c
The probes were end-labeled with 3zP and hybridized to the cDNA library in the hybridization solution of 20% formamide. 5 X SSC, 5 X Denhardt's solution, 0.05% sodium pyrophosphate and 0.1% sodium dodecyl sulfate (SDS) at 39°C for 16 hours. This WSXWS motif is the consensus sequence for the cytokine receptors. To avoid reisolation of known proteins with WSXWS motif, we searched in the gene bank for all proteins with nucleotide sequences identical to WSXWS consensus sequences and designed a 45-nt oligomer specific for each known protein located on regions other than the WSXWS motif. A mixture of these 45-mer oligonucleotides was used as a negative screening probe. The hybridization condition is the same as using mixed 15-mer, except the hybridization temperature was at 42°C. cDNA clones that hybridized with the WSXWS mixed probe, but did not hybridize with the mixture of specific 45-mer were picked and sequenced.
Isolation of genomic clones.
A human placenta genomic library (1 X IO6 plaque-forming units) cloned in lambda Fix I1 vector (Stratagene, La Jolla, CA) was screened with the full-length IL-9 receptor cDNA. The probe was labeled with 32P by the random primer method and hybridized to genomic library on nitrocellulose filter in hybridization in 50% formamide, 5 x SSC (1 x SSC is 0.15 m o m NaCl and 15 mmollL sodium citrate pH 7). 5 X Denhardt's solution (1 X Denhardt's solution is 0.02% Ficoll (Type 400; Pharmacia, Pis- cataway, NJ), 0.02% polyvinylpyrrolidone, and 0.02% bovine serum albumin), 0.05% sodium pyrophosphate, and 0.1% SDS for 16 hours at 42°C. Positive clones were further screened using two sets of oligonucleotide probes, one specific for the 5' end of the cDNA and another specific for the 3' end of the cDNA. These probes were endlabeled with [32P]adenosine triphosphate and used in hybridization in a 20% formamide hybridization solution (containing all the other reagents in the proportions described above) for 2 to 5 hours at 42°C. Forty positive clones that hybridized with both 5'-end and 3'-end probes were isolated, and phage DNA was prepared using the Magic Lambda Preps DNA Purification System with some modification (Promega, Madison, WI).
Preparation of Aphage DNA for sequencing. A Phage DNA was prepared by the Magic Lambda Preps DNA purification system with some modification to obtain cleaner X DNA for use as a sequencing template. After A DNA was eluted from the resin by following the protocol of the isolation kit, it was further purified by proteinase K (200 pglmL) treatment, phenol-chloroform extraction, and ethanol precipitation.
Nucleotide sequence analysis of the iL-9 receptor gene. For the genomic DNA sequence, X DNA prepared as described above was used as a template and synthetic oligonucleotide was used as primer. DNA sequences were determined by using the Prism Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) along with the 373A DNA sequencer (Applied Biosystems).
Construction offusion genes and assayfor their promoter activity. An 848-bp fragment (-2,431 bp to -1,584 bp as shown in Fig 4) of IL-9 receptor intron 1 region was generated by polymerase chain reaction (PCR) with two oligonucleotide primers (primer A1 and primer A2) with Hind111 site at the 5' end and NheI site at the 3' end. The amplified fragment was cloned into the pGL2-enhancer plasmid vector containing the entire coding sequence of firefly luciferase along with the SV40 enhancer (Promega) to generate a pIL-9R-int-enhancer fusion gene. The 659-bp fragment (-5,700 bp to -5,042 bp in Fig 4) containing IL-9 receptor exon 1 region was similarly amplified by PCR with two oligonucleotides, primer B1 and primer B2, and subcloned into PGL-2 enhancer vector to generate a pIL-9R-Pro-enhancer fusion gene. These two fusion genes were used along with the promoterless pGL2-enhancer plasmid in 
RESULTS
Isolation of human IL-9 receptor cDNA. To isolate the novel receptor specific for the growth or differentiation factor for megakaryocytes, we generated a cDNA library from human megakaryoblastic cell line UT-7.I4 A mixture of degenerate synthetic oligonucleotides encoding for WSXWS motif, a cytokine-receptor consensus sequence, was used as a hybridizing probe. We isolated several novel cDNA clones whose sequence encoded open reading frame with WSXWS motif. One of these clones was found to be 99% identical to that of the published IL-9 receptor cDNA, Ph9RA3, in the coding region." There are two differences in the sequences between our U41 cDNA clone and the published cDNA. In Ph9RA3, amino acid 331 is Arg, whereas in U41, it is Gly. The genomic sequence is identical to the U41 cDNA sequence at this position. The second difference occurs at the S' end of the cDNA sequences. AIignment of the S' end of the nucleotide and amino acid sequences of U41 and 
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Ser P r o Arg AAC TTC CAG A 6 n P h e G l n 301 302 303 the alternative splicing. To prove that our cDNA isolated from UT-7 cells is not an artifact obtained in the process of cDNA library construction, a human embryonic kidney cell line, 293, was used as an independent source of mRNA. A S' 500-bp fragment specific for human IL-9 receptor cDNA was isolated from 293 cells by reverse transcription and PCR. Nucleotide sequence of this fragment shows identical sequences to that of U41 cDNA isolated from UT-7 cells. It also contains the 179-bp insertion. In the U41 cDNA, the putative translation initiation codon is different from that of the Ph9RA3. Termination codons are present in all three reading frames upstream of the putative translation initiation codon in U41. The first 23 residues of the deduced amino acid sequence of U41 fit the hydrophobic profile of a signal peptide, and the amino terminal residue of the mature protein of IL-9 receptor is predicted to be glutamic acid.
Genomic structure of human IL-9 receptor gene. A total of 1 X lo6 recombinant phages were screened with a fulllength cDNA clone of human IL-9 receptor and 40 positive clones were isolated. One of the genomic clones, clone 36, was analyzed. Its complete nucleotide sequence was determined. The nucleotide sequences of the coding regions were identical to that of the cDNA clone. As shown in Fig 2, the gene spans 13 kb and consists of 10 exons and 9 introns. The extracellular domain is encoded by exon 3 to exon 7. The transmembrane domain is encoded by exon 8 and the cytoplasmic domain is encoded by exons 9 and 10. The sequences of intron-exon junction conform to the consensus sequence of eukaryotic splice junction (Fig 3) . This assignment of the exon-intron boundaries is based on our cDNA clone U41 isolated from UT-7 cells. Alternatively, in the published cDNA, PH9RA3, exon 2 would be skipped and would be part of intron 1.
Search for potential regulatory sequences. Many sequences regulating transcription, as well as the nuclear factors with which they interact, have been extensively ~haracterized.'~ Figure 4 shows the genomic sequences of the 5' noncoding region of the L -9 receptor gene. We have identified two putative TATA boxes and several potential regulatory elements in this region. In the intron 2, there are NJK-B (-1,407 bp), SP-1 (-1,177 bp), glucocorticoid response element (-937 bp) and AP-l (-245 and -310 bp). In the intron 1, there are regulatory sequences of AP-2 (-2,409 bp), Oct 2 (-2,248 bp), AP-4 (-1,648 bp) and one putative TATA box (-2,173 bp). In the exon 1, there are AP-3 (-5,226 bp) and SP-1 (-5,211 bp). Upstream of the cDNA start site (-5,245 bp),'l there is another TATA box. Therefore, the region from -5,700 to -5,245 could be the potential promoter region.
For TTCATGGGGA GCACCCCTCC AGAGAGGGAT GATTTGCACA GGGCCCTCAG Promoter activity. There are two putative TATA boxes in the 5' noncoding region. One is located at intron 1 (-2,173 bp), the other is located upstream of the cDNA start site (-5,145 bp). To determine the ability of the putative regulatory elements to function as a promoter, we constructed two fusion genes in which a firefly luciferase reporter gene was placed downstream under the control of the regulatory elements. One fusion gene, PIL-9R-pro-enhancer, contains a regulatory fragment of 659 bp (nucleotide -5,700 to -5,042) including exon 1 sequences. The other fusion gene, PIL-9R-int-enhancer, contains a regulatory fragment of 848 bp (nucleotide -2,431 to -1,584) including partial intron 1 sequences. The fusion gene was transfected into the human kidney 293 or NIH3T3 cells. Seventy-two hours after transfection, the expression of luciferase activity was analyzed with or without induction of phorbol-12-myristate-13 acetate (PMA). Transfection analysis showed that this 659-bp fragment containing exon 1 acts as an active promoter for the downstream reporter gene in the 293 cells, but not in the NIH3T3 cells (Table 1) . It showed 16.8-fold increase in luciferase activity over the promoterless control vector. However, the 848-bp fragment from intron 1 also enhanced the luciferase activity by 2.2-fold over the control vector.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From The 293 Furthermore, the promoter activity can be induced by PMA treatment (Table 1 ). The result is consistent with our earlier observation that mRNA expression level of IL-9 receptor can be induced by PMA treatment in the UT-7 cells (data not shown). These data show that the promoter activity of the 659-bp fragment in the IL-9 receptor gene is cell-specific and can be induced by PMA.
DISCUSSION
We have isolated the genomic clone of the IL-9 receptor and determined the genomic sequence and structure of the gene. The genomic structure consists of 10 exons. Exons 3 through 7 encode the extracellular domain, exon 8 encodes the transmembrane domain, and exons 9 and 10 encode the cytoplasmic domain. The genomic structures of several members of the cytokine receptor superfamily have been
Comparison of the genomic structure of the IL-9 receptor with other members of the family shows a considerable homology of their genomic structure. As shown in Fig 5, the extracellular domains of most cytokine receptors are encoded by 4 exons. Two of them contain the four conserved cysteine residues and the exon next to the transmembrane domain exon contains the WSXWS motif. The structural homology supports the theory that the IL-9 receptor and other members of the cytokine receptor superfamily derived from a primordial gene by gene duplication.
The gene encoding the ligands of these receptors may also be derived from a common ancestor. The interleukins and colony-stimulating factors have similar exon-intron structure and share the same elements regulating gene expression.21.22 This phenomenon suggests that hematopoietic growth factors and their receptors have evolved from a single primordial growth factor gene and a single primordial receptor gene. The current complex system of factors and receptors reflects the evolution of the immune system as a whole.
Recent studies have shown that a section of the cytoplasmic domain that includes the serine-rich region appears to have a critical role for mitogenic signal transduction. This critical region shows the highest degree of homology between IL-2RP subunit and murine erythropoietin recept~r . *~. *~ Both human and murine IL-9 receptors also contain a high percentage of serine and proline in their cytoplasmic domain.13 The proline-and serine-rich region in all three receptors are encoded by the last exon. This suggests that the last exon of these three receptors may involve the mitogenic signal transduction.
Comparison of our cDNA sequence with that of the published cDNA showed that there are some discrepancies in the 5' end. The difference between the U41 cDNA sequence and the published cDNA sequence could be caused by the differential splicing. In the process of screening the cDNA library from UT-7 cells, we isolated several full-length cDNA clones of different sizes. Nucleotide sequence analysis of some clones showed that there are differential splicings in the 5'-end or 3'-end noncoding region. Based on PCR analysis, we have observed that the IL-9 receptor is ex- The assignment of the translation initiation codon in U41 cDNA is different from that of the published Ph9RA3 cDNA. Renauld et all3 assigned the translation initiation site at the first methionine (Fig IB) . Our hydrophobicity analysis of their signal peptide sequences did not match with a signal peptide profile. However, if the translation initiation site in ph9RA3 cDNA was assigned to the second methionine (same methionine as U41 cDNA), the following 22 amino acids fit perfectly with the hydrophobicity profile. Therefore, the mature protein of IL-9 receptor should be glutamic acid instead of valine. Assignment of either first methionine or second methionine as a translation start site follows Kozak's rules on +4 position (ATGG), but neither of them follow the rules on -3 position.
The fusion gene, PIL-9R-pro-enhancer, containing 659 bp (nucleotide -5,700 to -5,042) showed a 16.8-fold increase in luciferase activity over the control vector. Whereas the fusion gene, PIL-9R-int-enhancer, containing 848 bp from intron 1 showed a 2.2-fold increase luciferase activity over the control vector. Therefore, the 659-bp fragment is 7.5-fold more active than the 848-bp fragment. It appears that the 659-bp region contains the promoter, and the TATA box identified in the intron 1 may not be the true start site. However, this 848 bp may contain an enhancer.
We have sequenced additional 500 bp of further 5' end of the gene (data not shown in Fig 4) and identified two Alu repeats. We know of no case that Alu repeats are present in the first exon of a human gene. This further supports our belief that the transcription start site is located in the 659-bp region and the TATA box at position -5,580 bp is the best candidate. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
